phenytoin has been researched along with Ischemic Stroke in 1 studies
Ischemic Stroke: Stroke due to BRAIN ISCHEMIA resulting in interruption or reduction of blood flow to a part of the brain. When obstruction is due to a BLOOD CLOT formed within in a cerebral blood vessel it is a thrombotic stroke. When obstruction is formed elsewhere and moved to block a cerebral blood vessel (see CEREBRAL EMBOLISM) it is referred to as embolic stroke. Wake-up stroke refers to ischemic stroke occurring during sleep while cryptogenic stroke refers to ischemic stroke of unknown origin.
Excerpt | Relevance | Reference |
---|---|---|
"In this propensity score-weighted population-based retrospective cohort study, we used competing risk regression analyses to determine the risks of ischemic stroke, venous thromboembolism, and death in DOAC recipients taking CYP/P-gp-modulating antiseizure medications (phenytoin, valproate, levetiracetam, carbamazepine, or phenobarbital) versus those taking CYP/P-gp-neutral antiseizure medications (pregabalin, gabapentin, or clobazam)." | 4.12 | Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis. ( Chan, HH; Chan, HY; Ip, BY; Ko, H; Lau, AY; Lau, LH; Leng, X; Leung, H; Leung, TW; Mok, VC; Soo, YO; Wong, GL; Yip, TC, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ip, BY | 3 |
Ko, H | 3 |
Wong, GL | 3 |
Yip, TC | 3 |
Lau, LH | 3 |
Lau, AY | 3 |
Leng, X | 3 |
Leung, H | 3 |
Chan, HH | 3 |
Chan, HY | 3 |
Mok, VC | 3 |
Soo, YO | 3 |
Leung, TW | 3 |
1 other study available for phenytoin and Ischemic Stroke
Article | Year |
---|---|
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Topics: Anticoagulants; Humans; Ischemic Stroke; Levetiracetam; Phenytoin; Retrospective Studies; Valproic A | 2022 |